Breaking news

Why the UAE Is Becoming A Premier Destination For Medical Tourism

With a commitment to enhancing its healthcare offerings, the UAE has positioned itself as a leader in medical tourism, catering to a growing global demand. As countries focus on improving the health of their populations, the UAE stands out for its strategic investments in both healthcare infrastructure and its appeal to medical tourists.

According to Statista, the global medical tourism market was valued at $47 billion in 2024, with projections indicating it could exceed $111 billion by 2029. The UAE is setting the bar high, with innovative initiatives such as specialized portals for health tourists and streamlined entry processes for medical visitors.

Tailored Portals And Seamless Experiences

Abu Dhabi and Dubai have launched dedicated online platforms that streamline the process for medical tourists. These portals offer a range of services, including healthcare provider contact information, appointment bookings, hotel reservations, and local transportation. Dubai Health Authority (DHA) introduced the Dubai Health Experience (DXH) brand in 2016, aimed at making the city a global leader in health tourism. The platform offers a curated selection of top-tier treatments in fields such as dentistry, fertility, ophthalmology, and cosmetic surgery.

Meanwhile, in 2018, Abu Dhabi’s Department of Health (DoH) rolled out its own e-portal, showcasing a network of over 40 healthcare facilities that meet the stringent quality standards of the DoH’s JAWDA program. Visitors can explore nearly 300 treatment packages across specialties ranging from routine check-ups to complex surgeries.

Simplified Access With Specialized Permits

To further attract international patients, the UAE offers specialized entry permits for medical tourists and their companions. These permits, which can be single or multiple entries, are sponsored by medical institutions and processed by relevant authorities in the country. Dubai Healthcare City also introduced a new medical visa in January 2024, allowing treatment centers to apply for permits on behalf of patients for stays of up to six months. This move bolsters Dubai’s reputation as a medical tourism hotspot.

The city welcomed 674,000 medical tourists in 2022, generating $270 million in revenue. Wellness tourism is also booming in the UAE, with visitors spending $5.4 billion in 2022—almost double the amount spent in 2020.

Innovation At The Forefront

The UAE’s innovative spirit continues to propel its rise as a medical tourism hub. In 2024, HealthStay.io, the world’s first AI-powered medical tourism solution, launched in partnership with Dubai Health Experience. This startup, part of the Mohammed Bin Rashid Innovation Fund’s Accelerator Program, uses artificial intelligence to automate the medical tourism journey, including selecting treatments and booking appointments.

“The launch of HealthStay.io is a direct result of the support from DXH and DHA, helping us transform Dubai into a global healthcare tourism leader,” said Ruairi Tubrid, co-founder of HealthStay.io. Fatima Yousif Alnaqbi, MBRIF representative, emphasized the importance of accelerator programs in supporting innovative solutions that elevate the UAE’s standing as a center of excellence in healthcare.

Government Commitment To Healthcare Excellence

The UAE’s rapid growth in medical tourism is rooted in its consistent focus on healthcare improvement. Key strategies such as the Emirates Health Services Innovation Strategy 2023-2026 and the National Strategy for Wellbeing 2031 aim to enhance residents’ quality of life and elevate the nation’s healthcare offerings.

Compared to its Gulf Cooperation Council (GCC) counterparts, the UAE leads in healthcare expenditure growth. Projections from Alpen Capital estimate that healthcare spending will reach $30.7 billion by 2027, reflecting the nation’s ongoing dedication to strengthening its healthcare infrastructure. As a result, the UAE continues to attract international patients seeking top-tier medical services.

SoftBank Shares Tumble Amid Tech Profit Taking And High-Risk AI Investments

Market Sell-Off And Profit Taking

SoftBank Group’s share price plunged over 11% following an overnight sell-off in the U.S. market, as broader profit taking in the technology sector weighed on investor sentiment. Major Asian technology players, including TSMC and Foxconn, experienced similar declines, reflecting a cautious approach among investors despite recent gains.

High-Stakes AI Investments

Despite this short-term volatility, SoftBank’s year-to-date share price surge of approximately 70% is largely fueled by robust investor enthusiasm around its high-risk bets on artificial intelligence. Concerns persist over these aggressive investments, even as the market continues to rally on the promise of AI-driven returns.

Global Technology Landscape

In the broader market, South Korean giants such as Samsung and SK Hynix witnessed modest declines of 1.25% and 2.75%, respectively, following profit taking after surpassing key market valuations. Similarly, overnight in the U.S., semiconductor leader Nvidia fell 3.62%, while Alphabet and Amazon saw declines of 0.79% and 2.5%, respectively.

Long-Term Vision Versus Short-Term Focus

SoftBank CEO Masayoshi Son has been vocal about the transformative potential of artificial intelligence, predicting that the AI revolution could be 50 times larger than the dot-com boom of the 2000s. However, as noted in a recent investor note by Deutsche Bank analyst Peter Milliken, market enthusiasm appears narrowly fixated on short-term momentum rather than a detailed long-term roadmap.

Strategic Asset Reallocation

Adding another layer to the unfolding narrative, SoftBank recently divested a 3.25% stake in Indian eyewear maker Lenskart through its affiliate SVF II Lightbulb (Cayman). The transaction, which involved selling 56.5 million shares at 508.55 Indian rupees each (approximately $5.32 per share), valued the deal at nearly 28.73 billion rupees. Following the sale, SoftBank’s shares traded at 7,377 yen, marking an 11.3% drop.

This dynamic environment underscores the challenges of balancing aggressive, innovation-driven investments with the need for prudent risk management in volatile markets.

Uol
Aretilaw firm
The Future Forbes Realty Global Properties
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter